Clinical practice guidelines for peritoneal dialysis in patients with chronic kidney disease stage 5 (CKD 5)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

E. V Shutov

O. N Kotenko

References

  1. Абдрашитова Г.Т., Серпик В.Г., Ягудина Р.И. Фармакоэкономический анализ оказания медицинской помощи больным с хронической болезнью почек, нуждающимся в проведении заместительной почечной терапии методами перитонеального диализа и гемодиализа в условиях Российского здравоохранения. Фармакоэкономика: теория и практика. 2015; 3: (3)
  2. Приказ Министерства здравоохранения и социального развития РФ от 18 января 2012 г. N 17н «Об утверждении Порядка оказания медицинской помощи взрослому населению по профилю “нефрология”».
  3. Sorkin M.I., Diaz-Buxo J.A. Physiology of Peritoneal Dialysis. In: Handbook of Dialysis Ed. Daugirdas J.T., Ing T.S.1994: 245-261.
  4. Шутов Е.В. Перитонеальный диализ. М. 2000.
  5. Levey A.S., Stevens L.A., Schmid C.H. et al. A new equation to estimate glomerular filtration rate. Ann.Intern.Med 2009; 150: 604-612.
  6. Cho Y., Johnson D.W., Craig J.C., et al. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst. Rev. 2014; 3: CD007554.
  7. Cice G., Di Benedetto A., D’Isa S., et al. Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial. J. Am. Coll. Cardiol. 2010; 56: 1701-1708.
  8. Blake P.G., Bargman J.M., et al. Clinical practice guidelines and recommendations on peritoneal dialysis adequacy 2011. Perit. Dial. Int. 2011; 31: 218-239.
  9. Bredie S.J., Bosch F.H., Demacker P.N., et al. Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit. Dial. Int. 2001; 21: 275-281.
  10. Wolfson M., Piraino B., Hamburger R.J., Morton A.R. on behalf of the Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icod extrininperitoneal dialysis. Am. J. Kidney Dis. 2002; 40: 1055-1065.
  11. Li P.K., Culleton B.F., Ariza A., et al. on behalf of the IMPENDIA and EDEN Study Groups. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J. Am. Soc.Nephrol. 2013; 24: 1889-900.
  12. Himmele R., Jensen L., Fenn D., Ho C.H., Sawin D.A., Diaz-Buxo J.A. A new neutral pH low GDP peritoneal dialysis fluid. Perit. Dial. Int. 2012; 32: 444-452.
  13. Johnson D.W., Brown F.G., Clarke M. et al. The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial. Perit. Dial. Int. 2012; 32(5): 497-506.
  14. European Best Practice Guidelines for Peritoneal Dialysis. Nephrol. Dial. Transplant. 2005; 20.
  15. Mujais S., Nolph K., Gokal R. et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit. Dial. Int. 2000; 20(4): S5-21.
  16. Peritoneal Dialysis-Related Infections Recommendations: 2010 Update. Perit. Dial.Int. 2010; 30: 393.
  17. Национальные клинические рекомендации по лечению пациентов с хронической болезнью почек 5-й стадии (ХБП-5) перитонеальным диализом, 2016. [National clinical guidelines for the treatment of patients with chronic kidney disease 5th stage (CKD-5) peritoneal dialysis, 2016. (In Russ.)].
  18. Twardowski Z., Nolph K. Khanna R Peritoneal equilibration test. Perit. Dial. Bull. 1987; 7.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies